The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction

Carl E. Orringer, Michael J. Blaha, Ron Blankstein, Matthew J. Budoff, Ronald B. Goldberg, Edward A. Gill, Kevin C. Maki, Laxmi Mehta, Terry A. Jacobson

Research output: Contribution to journalArticlepeer-review

Abstract

An Expert Panel of the National Lipid Association reviewed the evidence related to the use of coronary artery calcium (CAC) scoring in clinical practice for adults seen for primary prevention of atherosclerotic cardiovascular disease. Recommendations for optimal use of this test in adults of various races/ethnicities, ages and multiple domains of primary prevention, including those with a 10-year ASCVD risk <20%, those with diabetes or the metabolic syndrome, and those with severe hypercholesterolemia were provided. Recommendations were also made on optimal timing for repeat calcium scoring after an initial test, use of CAC scoring in those taking statins, and its role in informing the clinician patient discussion on the benefit of aspirin and anti-hypertensive drug therapy. Finally, a vision is provided for the future of coronary calcium scoring.

Original languageEnglish (US)
Pages (from-to)33-60
Number of pages28
JournalJournal of clinical lipidology
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2021

Keywords

  • Atherosclerotic cardiovascular disease risk prediction
  • Computed tomography
  • Coronary artery calcium scoring
  • Subclinical coronary atherosclerosis

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction'. Together they form a unique fingerprint.

Cite this